{"id":261118,"date":"2026-09-22T10:52:06","date_gmt":"2026-09-22T05:22:06","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=261118"},"modified":"2026-09-30T10:32:13","modified_gmt":"2026-09-30T05:02:13","slug":"why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/","title":{"rendered":"SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA): SURAKSHA 52 Week High Streak: Second Straight Session Near Peak"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/suraksha\/suraksha-diagnostic-limited-share-price-today\">SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 353.3, down 0.56% from the previous close. Market cap was Rs 1,809.55 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><strong>SURAKSHA 52 Week High Streak<\/strong> has now held for a <strong>second straight session<\/strong>, with the stock trading within 2% of its one-year peak across both sessions. The latest reading places the share price at Rs 353.3, while the cumulative move across the streak stands at 1.68%. The latest Univest figures confirm the repeated near-high pattern, but they do not establish a company-specific catalyst for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">As of 30 September 2026 at 10:22 AM IST, SURAKSHA last traded at Rs 353.3 versus a previous close of Rs 355.3, after opening at Rs 355 and touching a low of Rs 350. The stock\u2019s market capitalisation stands at Rs 1,809.55 crore. For readers, a repeated near 52-week high pattern is different from a single-day move because it shows persistence around the yearly peak rather than one isolated print.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#SURAKSHA_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"SURAKSHA 52 Week High Streak: Consecutive High Analysis\">SURAKSHA 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#SURAKSHA_DIAGNOSTIC_LIMITED_SURAKSHA_Fundamental_Analysis\" title=\"SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Fundamental Analysis\">SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_SURAKSHA\" title=\"Why Investors Are Watching SURAKSHA\">Why Investors Are Watching SURAKSHA<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#About_SURAKSHA_DIAGNOSTIC_LIMITED\" title=\"About SURAKSHA DIAGNOSTIC LIMITED\">About SURAKSHA DIAGNOSTIC LIMITED<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#What_does_SURAKSHA_52_Week_High_Streak_mean\" title=\"What does SURAKSHA 52 Week High Streak mean?\">What does SURAKSHA 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Is_SURAKSHA_at_a_new_52-week_high_today\" title=\"Is SURAKSHA at a new 52-week high today?\">Is SURAKSHA at a new 52-week high today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#What_is_the_cumulative_move_in_the_SURAKSHA_52_Week_High_Streak\" title=\"What is the cumulative move in the SURAKSHA 52 Week High Streak?\">What is the cumulative move in the SURAKSHA 52 Week High Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#What_is_the_latest_SURAKSHA_share_price\" title=\"What is the latest SURAKSHA share price?\">What is the latest SURAKSHA share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Why_are_investors_watching_SURAKSHA_stock_now\" title=\"Why are investors watching SURAKSHA stock now?\">Why are investors watching SURAKSHA stock now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Is_SURAKSHA_expensive_on_valuation\" title=\"Is SURAKSHA expensive on valuation?\">Is SURAKSHA expensive on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#How_does_SURAKSHA_compare_with_healthcare_peers\" title=\"How does SURAKSHA compare with healthcare peers?\">How does SURAKSHA compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#What_should_readers_monitor_next_in_SURAKSHA_stock_analysis\" title=\"What should readers monitor next in SURAKSHA stock analysis?\">What should readers monitor next in SURAKSHA stock analysis?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-suraksha-diagnostic-limited-share-near-52-week-consecutive-high-2026\/#Track_SURAKSHA_DIAGNOSTIC_LIMITED_SURAKSHA_Share_Price_on_Univest\" title=\"Track SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price on Univest\">Track SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SURAKSHA_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>SURAKSHA 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 353.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 355.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2 (-0.56%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 355<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 355.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 350<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,809.55 crore<\/td>\n<\/tr>\n<\/table>\n<p>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) traded at Rs 353.3 versus the previous close of Rs 355.3, a fall of 0.56%. The stock opened at Rs 355, reached a high of Rs 355.15 and touched a low of Rs 350.<\/p>\n<p>SURAKSHA share price today shows a mild pullback from the previous close, with the stock last traded at Rs 353.3 after a change of Rs -2, or -0.56%. It opened at Rs 355 and moved between Rs 350 and Rs 355.15 during the trading window captured at 30 September 2026 at 10:22 AM IST. That places the current price close to the upper end of the day\u2019s range, even though it is below the previous close. The market capitalisation of Rs 1,809.55 crore helps frame the stock within the healthcare space, while the near-high streak keeps it in the \u201cStocks At One Year High Today\u201d conversation. For SURAKSHA share price readers, the key point is not only today\u2019s change but the fact that SURAKSHA 52 Week High Streak has persisted for a second straight session. The pattern keeps SURAKSHA in the spotlight of stock news searches and share price update queries, but it does not by itself explain why the share price has stayed near the yearly peak.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The repeated high pattern shows that SURAKSHA 52 Week High Streak is not just a one-off event. SURAKSHA has traded within 2% of its 52-week high for a second straight session, and that makes the move more relevant for readers tracking 52 Week High Stocks and Stocks Hitting 52 Week Highs. The cumulative streak move of 1.68% is modest, which is important because it separates the streak from a sharp single-session jump. It tells readers that the stock has remained close to its yearly peak rather than making a large leap away from it. The latest Univest figures confirm the price pattern, but they do not confirm a company-specific reason behind it. In practical terms, SURAKSHA Consecutive 52 Week Highs are a signal to track the share price closely, especially when the stock is already trading near the upper end of its recent range.<\/p>\n<p>For investors and traders following SURAKSHA New One Year High searches, the repeated pattern matters because it suggests continuity in market interest around the stock price, without making any claim about the cause. The key observation is simple: SURAKSHA Back To Back 52 Week Highs have now appeared across two sessions, and the stock remains near the 52-week peak rather than drifting far away from it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SURAKSHA_DIAGNOSTIC_LIMITED_SURAKSHA_Fundamental_Analysis\"><\/span><strong>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,809.55 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.81%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.97%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6.87<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 49.28<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.14%<\/td>\n<\/tr>\n<\/table>\n<p>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) fundamental metrics show P\/E 51.69x, P\/B 7.21x, ROE 13.81%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>SURAKSHA DIAGNOSTIC LIMITED has a market capitalisation of Rs 1809.55 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 51.69x, P\/B at 7.21x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.81% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.87, book value per share of Rs 49.28, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 42.95x, median ROE of 12.88%, median ROCE of 15.77%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">42.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">89.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,572.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.81%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.97%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,809.55 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 533.06 crore<\/td>\n<\/tr>\n<\/table>\n<p>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) is classified under sector: Healthcare and industry: Hospital &amp; Healthcare Services.<\/p>\n<p>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P\/E ratio of 51.69x, which is above the benchmark median of 42.95x, a difference of +20.35%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROE of 13.81%, which is above the benchmark median of 12.88%, a difference of +7.22%. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROCE of 24.97%, which is above the benchmark median of 15.77%, a difference of +58.34%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/krsnaa\/krsnaa-diagnostics-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Krsnaa Diagnostics Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KRSNAA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,737.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.08<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/shalby\/shalby-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Shalby Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SHALBY<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,549.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.88<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gksl\/gujarat-kidney-n-sup-sp-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>GUJARAT KIDNEY N SUP SP L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GKSL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,371.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">88.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,498.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.21<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gpthealth\/gpt-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>GPT Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GPTHEALTH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,280.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.06<\/td>\n<\/tr>\n<\/table>\n<p>SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P\/E ratio of 51.69x compared with the displayed peer median of 32.78x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.81% compares with a peer median of 12.08% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 15.51%, providing a capital-efficiency comparison. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a market capitalisation of Rs 1,809.55 crore. Among the 5 peers shown, 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SURAKSHA\"><\/span><strong>Why Investors Are Watching SURAKSHA<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>SURAKSHA 52 Week High Streak has held for a second straight session, keeping the share price near the yearly peak.<\/li>\n<li>The cumulative streak move stands at 1.68%, which helps separate this pattern from a one-session price jump.<\/li>\n<li>SURAKSHA share price is trading at Rs 353.3, close to the upper end of the day\u2019s range.<\/li>\n<li>The company\u2019s P\/E ratio of 51.69 and P\/B ratio of 7.21 place it above the industry median on valuation.<\/li>\n<li>ROE of 13.81% and ROCE of 24.97% provide a useful fundamental backdrop for SURAKSHA stock analysis.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SURAKSHA_DIAGNOSTIC_LIMITED\"><\/span><strong>About SURAKSHA DIAGNOSTIC LIMITED<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SURAKSHA DIAGNOSTIC LIMITED operates in the healthcare space under the Hospital &#038; Healthcare Services industry. The company\u2019s share price, market cap and valuation metrics place it among the closely tracked healthcare names in the latest Univest data set. For readers following SURAKSHA Stock News, the key watchpoints are the company\u2019s market capitalisation, earnings quality indicators such as EPS and book value, and return ratios including ROE and ROCE. The stock\u2019s repeated proximity to its 52-week high has added another layer of interest to SURAKSHA share price discussions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_SURAKSHA_52_Week_High_Streak_mean\"><\/span><strong>What does SURAKSHA 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>It means SURAKSHA has traded within 2% of its 52-week high for a second straight session. The pattern shows repeated proximity to the yearly peak, which is why it appears in stock news and share price searches.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_SURAKSHA_at_a_new_52-week_high_today\"><\/span><strong>Is SURAKSHA at a new 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No. The latest reading shows the stock is trading near its 52-week high, not necessarily setting a fresh peak in the current session. The key point is the repeated closeness over consecutive sessions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_in_the_SURAKSHA_52_Week_High_Streak\"><\/span><strong>What is the cumulative move in the SURAKSHA 52 Week High Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The cumulative move across the streak is 1.68%. That figure captures the full movement across the consecutive sessions in which the stock stayed within 2% of its one-year high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_SURAKSHA_share_price\"><\/span><strong>What is the latest SURAKSHA share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>SURAKSHA last traded at Rs 353.3 as of 30 September 2026 at 10:22 AM IST. The stock was slightly below the previous close of Rs 355.3 at the time captured.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_are_investors_watching_SURAKSHA_stock_now\"><\/span><strong>Why are investors watching SURAKSHA stock now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Investors are watching the repeated near-high pattern, the premium valuation, and the company\u2019s return ratios. Those factors together make SURAKSHA a closely tracked name among 52 Week High Stocks and healthcare shares.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_SURAKSHA_expensive_on_valuation\"><\/span><strong>Is SURAKSHA expensive on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Based on the latest figures, SURAKSHA trades at a P\/E of 51.69 and a P\/B of 7.21, both above the industry median in the same healthcare peer set. That places it on the higher side of valuation comparisons.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SURAKSHA_compare_with_healthcare_peers\"><\/span><strong>How does SURAKSHA compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>SURAKSHA is valued above several peers on P\/E and P\/B, while its ROE and ROCE are above the industry median. That mix makes it a different kind of healthcare share price story from lower-multiple peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_readers_monitor_next_in_SURAKSHA_stock_analysis\"><\/span><strong>What should readers monitor next in SURAKSHA stock analysis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Readers should monitor whether the stock continues to trade near its 52-week peak, whether the streak extends, and how valuation compares with sector and peer benchmarks. The latest pattern is clear, while the company-specific driver remains unconfirmed.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SURAKSHA_DIAGNOSTIC_LIMITED_SURAKSHA_Share_Price_on_Univest\"><\/span><strong>Track SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/suraksha\/suraksha-diagnostic-limited-share-price-today\">SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SURAKSHA DIAGNOSTIC LIMITED Share Price trades near its 52-week high at Rs 353.3, marking a -0.56% rise today. Market cap stands at Rs 1,809.55 crore.<\/p>\n","protected":false},"author":38,"featured_media":279919,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-261118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["279919"],"rank_math_title":["SURAKSHA 52 Week High Streak: Fundamental and Sector View"],"rank_math_description":["SURAKSHA 52 Week High Streak continues for a second straight session, with the stock near its one-year peak, plus valuation, sector and peer context."],"rank_math_focus_keyword":["SURAKSHA 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/suraksha-diagnostic-limited-suraksha-suraksha-52-week-high-streak-second.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=261118"}],"version-history":[{"count":3,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261118\/revisions"}],"predecessor-version":[{"id":279920,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261118\/revisions\/279920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/279919"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=261118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=261118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=261118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}